MPI Research, inviCRO, and 3D Imaging Announce Strategic Partnership

Published: Jun 12, 2013

Staying up-to-date has never been simpler. Sign up for the free GenePool newsletter today!

MATTAWAN, Mich.--(BUSINESS WIRE)--MPI Research, the largest single-site preclinical/early clinical contract research organization (CRO) globally, is pleased to announce a strategic partnership with inviCRO and 3D Imaging to unite world-class molecular imaging, radiochemistry, and informatics to accelerate drug discovery and development. This partnership represents a combination of integrated imaging solutions that is offered by no other CRO in the world. Having already collaborated on more than 100 unique imaging projects, MPI Research, inviCRO, and 3D Imaging are aligning and expanding to meet the industry’s need for comprehensive imaging services in a single location. The new molecular imaging center, located at MPI Research, will provide drug developers with access to the first commercially available cyclotron facility immediately contiguous with vivarium facilities housing species ranging from mice to nonhuman primates.

Help employers find you! Check out all the jobs and post your resume.

Back to news